Fortis Malar Hospitals Ltd
Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of providing health care & medical services[1]
- Market Cap ₹ 140 Cr.
- Current Price ₹ 74.6
- High / Low ₹ 98.7 / 51.0
- Stock P/E 341
- Book Value ₹ 16.0
- Dividend Yield 56.9 %
- ROCE 0.86 %
- ROE 0.59 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 4.67 times its book value
- Company has a low return on equity of -9.37% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
108.38 | 117.93 | 129.61 | 140.56 | 149.19 | 144.59 | 111.87 | 69.24 | 86.18 | 85.95 | 59.01 | 0.00 | |
99.41 | 110.39 | 123.33 | 139.66 | 147.47 | 146.94 | 114.52 | 75.56 | 82.72 | 81.37 | 60.20 | 2.12 | |
Operating Profit | 8.97 | 7.54 | 6.28 | 0.90 | 1.72 | -2.35 | -2.65 | -6.32 | 3.46 | 4.58 | -1.19 | -2.12 |
OPM % | 8.28% | 6.39% | 4.85% | 0.64% | 1.15% | -1.63% | -2.37% | -9.13% | 4.01% | 5.33% | -2.02% | |
6.56 | 7.35 | 6.95 | 7.54 | 8.18 | 9.60 | 10.84 | 14.93 | 7.33 | 6.56 | 66.80 | 2.72 | |
Interest | 0.46 | 0.51 | 0.40 | 0.46 | 0.38 | 0.51 | 7.81 | 7.20 | 6.56 | 6.07 | 4.30 | 0.01 |
Depreciation | 1.99 | 2.71 | 3.16 | 3.94 | 4.21 | 4.38 | 12.53 | 12.88 | 12.53 | 12.15 | 9.36 | 0.00 |
Profit before tax | 13.08 | 11.67 | 9.67 | 4.04 | 5.31 | 2.36 | -12.15 | -11.47 | -8.30 | -7.08 | 51.95 | 0.59 |
Tax % | 34.48% | 34.36% | 35.68% | 29.95% | 40.87% | 26.69% | -25.51% | -30.08% | 0.00% | 119.49% | 8.99% | 30.51% |
8.56 | 7.66 | 6.23 | 2.82 | 3.14 | 1.74 | -9.06 | -8.01 | -8.31 | -15.53 | 47.28 | 0.41 | |
EPS in Rs | 4.60 | 4.12 | 3.35 | 1.51 | 1.68 | 0.93 | -4.83 | -4.27 | -4.43 | -8.29 | 25.23 | 0.22 |
Dividend Payout % | 10.87% | 12.15% | 14.94% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 168.63% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | -25% |
5 Years: | 15% |
3 Years: | 27% |
TTM: | 107% |
Stock Price CAGR | |
---|---|
10 Years: | 4% |
5 Years: | 11% |
3 Years: | 11% |
1 Year: | 9% |
Return on Equity | |
---|---|
10 Years: | -4% |
5 Years: | -11% |
3 Years: | -9% |
Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 18.61 | 18.61 | 18.62 | 18.68 | 18.70 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 | 18.76 |
Reserves | 65.62 | 71.85 | 78.05 | 79.60 | 82.90 | 84.84 | 75.67 | 67.86 | 59.21 | 43.20 | 90.45 | 11.21 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 64.34 | 57.17 | 53.41 | 46.40 | 0.00 | 0.00 | |
16.49 | 19.48 | 32.36 | 30.83 | 45.74 | 44.90 | 32.64 | 23.20 | 27.30 | 27.33 | 6.18 | 6.60 | |
Total Liabilities | 100.72 | 109.94 | 129.03 | 129.11 | 147.34 | 148.50 | 191.41 | 166.99 | 158.68 | 135.69 | 115.39 | 36.57 |
17.63 | 17.71 | 24.50 | 24.59 | 23.79 | 21.85 | 81.08 | 68.52 | 57.62 | 47.41 | 0.00 | 0.00 | |
CWIP | 0.64 | 0.64 | 0.36 | 0.61 | 0.72 | 0.73 | 0.09 | 0.36 | 0.06 | 0.00 | 0.00 | 0.00 |
Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
82.40 | 91.54 | 104.12 | 103.86 | 122.78 | 125.87 | 110.19 | 98.06 | 100.95 | 88.23 | 115.34 | 36.52 | |
Total Assets | 100.72 | 109.94 | 129.03 | 129.11 | 147.34 | 148.50 | 191.41 | 166.99 | 158.68 | 135.69 | 115.39 | 36.57 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
5.75 | 4.18 | 10.70 | -10.34 | 9.75 | -15.73 | -0.27 | -1.20 | 6.80 | 5.61 | -7.21 | 1.77 | |
-1.42 | 5.23 | -22.00 | 15.18 | -2.29 | 6.11 | 48.31 | -27.60 | 8.18 | 0.43 | 119.62 | -27.30 | |
-1.10 | 0.00 | -1.09 | -0.97 | 0.05 | 0.15 | -11.57 | -7.25 | -10.10 | -12.65 | -10.85 | -79.65 | |
Net Cash Flow | 3.23 | 9.41 | -12.39 | 3.88 | 7.51 | -9.47 | 36.47 | -36.05 | 4.87 | -6.61 | 101.56 | -105.18 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 13.13 | 13.03 | 16.93 | 14.49 | 14.68 | 24.39 | 12.17 | 11.02 | 9.32 | 13.50 | 0.00 | |
Inventory Days | 4.02 | 13.24 | 35.39 | 28.37 | 22.30 | 18.04 | 22.44 | 42.32 | 39.89 | 31.71 | 0.00 | |
Days Payable | 153.11 | 169.12 | 286.36 | 172.55 | 275.68 | 254.81 | 323.38 | 374.86 | 428.69 | 584.12 | ||
Cash Conversion Cycle | -135.96 | -142.85 | -234.05 | -129.69 | -238.70 | -212.39 | -288.77 | -321.53 | -379.49 | -538.90 | 0.00 | |
Working Capital Days | 189.20 | 165.77 | 127.49 | 149.75 | 129.52 | 153.66 | -38.40 | 134.16 | 51.54 | 219.00 | 4.21 | |
ROCE % | 16.88% | 13.96% | 11.64% | 4.64% | 5.69% | 2.88% | -3.25% | -7.35% | -1.30% | -0.84% | -1.54% | 0.86% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 May - Copies of Newspaper Advertisement published on Business Standard (English Version) (all editions) and Rozana Spokesman (Punjabi Version) (Mohali Edition).
-
Appointment Of Secretarial Auditors And Cost Auditors
15 May - Audited FY25 results approved; no business operations post slump sale; new cost and secretarial auditors appointed.
- Outcome Of Board Meeting In Accordance With The SEBI (LODR) Regulations, 2015 15 May
-
Board Meeting Outcome for Outcome Of Board Meeting In Accordance With The SEBI (LODR) Regulations, 2015
15 May - Audited FY25 results with unmodified opinion; business sold, no operations; new cost and secretarial auditors appointed.
-
Board Meeting Intimation for To Consider And Approve The Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31, 2025.
7 May - Board meeting on May 15 to approve FY25 audited results; trading window closed till May 17.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
Company is a part of Fortis Group, being subsidiary of Fortis Hospitals Limited and Intermediate Holding Company of Fortis Healthcare Ltd. The Hospital building is owned by a fellow subsidiary, Fortis Health Management Limited. Company has entered into Hospital and Medical Services Agreement
with FHML for rendering of medical and healthcare services at the hospital building